253 related articles for article (PubMed ID: 2571421)
1. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.
Cerdan C; Lipcey C; Lopez M; Nunes J; Pierres A; Mawas C; Olive D
Cell Immunol; 1989 Oct; 123(2):344-53. PubMed ID: 2571421
[TBL] [Abstract][Full Text] [Related]
2. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
3. Signaling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation.
Yamada A; Kaneyuki T; Torimoto Y; Daley JF; Prado CM; Yokoyama MM
Cell Immunol; 1992 Jun; 142(1):145-58. PubMed ID: 1375131
[TBL] [Abstract][Full Text] [Related]
4. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
5. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
[TBL] [Abstract][Full Text] [Related]
6. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
7. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
[TBL] [Abstract][Full Text] [Related]
8. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells promote anti-CD3-induced T-cell proliferation via cell-cell contact mediated by LFA-1 and CD2.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; De Waal RM
Scand J Immunol; 1993 Nov; 38(5):435-44. PubMed ID: 7901894
[TBL] [Abstract][Full Text] [Related]
10. Only dull CD3+ thymocytes bind to thymic epithelial cells. The binding is elicited by both CD2/LFA-3 and LFA-1/ICAM-1 interactions.
Nonoyama S; Nakayama M; Shiohara T; Yata J
Eur J Immunol; 1989 Sep; 19(9):1631-5. PubMed ID: 2477252
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies.
Wesselborg S; Janssen O; Pechhold K; Kabelitz D
J Exp Med; 1991 Feb; 173(2):297-304. PubMed ID: 1703204
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
13. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
14. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
15. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.
Timonen T; Gahmberg CG; Patarroyo M
Int J Cancer; 1990 Dec; 46(6):1035-40. PubMed ID: 1979068
[TBL] [Abstract][Full Text] [Related]
16. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
17. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte function-associated antigen 1 is an activation molecule for human T cells.
Wacholtz MC; Patel SS; Lipsky PE
J Exp Med; 1989 Aug; 170(2):431-48. PubMed ID: 2569026
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
20. Activation of human T cells by neuraminidase-galactose oxidase-treated erythrocytes involving CD2 (T11) and its complementary structure.
Ocklind G; Talts J; Lindahl-Kiessling K
Scand J Immunol; 1988 Jun; 27(6):697-704. PubMed ID: 2899354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]